Risk Stratification for Diffuse Large B-Cell Lymphoma Integrating Interim 18f-FDG PET-CT Analysis and the National Comprehensive Cancer Network IPI: A Multicentre Retrospective Study
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-202458
Abstract: The treatment of diffuse large B-cell lymphoma (DLBCL) requires an accurate interim assessment of therapeutic effect. The prognostic evaluation of interim 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET-CT) remains controversial. Our objective was to assess… read more here.
Keywords: cell lymphoma; ipi; risk; diffuse large ... See more keywords
Prognostic role of early interim [18F] fluoro-deoxy-glucose positron emission tomography in patients with advanced seminoma undergoing standard treatment.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.5055
Abstract: 5055Background: In patients (pts) with advanced seminoma, efforts are underway to tailor a risk-adapted treatment strategy to the individual pt. Our main objective was to prospectively determine th... read more here.
Keywords: interim 18f; treatment; prognostic role; advanced seminoma ... See more keywords
Combined prognostic role of TARC and interim 18F-FDG PET/CT in patients with Hodgkin lymphoma-real world observational study.
Sign Up to like & getrecommendations! Published in 2022 at "Hellenic journal of nuclear medicine"
DOI: 10.1967/s002449912471
Abstract: OBJECTIVE Although the majority of patients with Hodgkin lymphoma (HL) has recently become long-term survivors, 20%-30% of HL patients have primary refractory disease or relapse. It is essential to identify patients at risk of treatment… read more here.
Keywords: 18f fdg; tarc levels; interim 18f; fdg pet ... See more keywords